Rusconi S - Search Results

1

Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.

Ensoli B, Bellino S, Tripiciano A, Longo O, Francavilla V, Marcotullio S, Cafaro A, Picconi O, Paniccia G, Scoglio A, Arancio A, Ariola C, Ruiz Alvarez MJ, Campagna M, Scaramuzzi D, Iori C, Esposito R, Mussini C, Ghinelli F, Sighinolfi L, Palamara G, Latini A, Angarano G, Ladisa N, Soscia F, Mercurio VS, Lazzarin A, Tambussi G, Visintini R, Mazzotta F, Di Pietro M, Galli M, Rusconi S, Carosi G, Torti C, Di Perri G, Bonora S, Ensoli F, Garaci E. Ensoli B, et al. Among authors: rusconi s. PLoS One. 2010 Nov 11;5(11):e13540. doi: 10.1371/journal.pone.0013540. PLoS One. 2010. PMID: 21085635 Free PMC article. Clinical Trial.

2

In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.

Rusconi S, Riva A, Meroni L, Zehender G, Cocchi F, Scapellato L, Galli M. Rusconi S, et al. Clin Exp Immunol. 1995 Oct;102(1):26-30. doi: 10.1111/j.1365-2249.1995.tb06631.x. Clin Exp Immunol. 1995. PMID: 7554395 Free PMC article.

3

Tracheoesophageal fistula in an HIV-1-positive man due to dual infection of Candida albicans and cytomegalovirus.

Rusconi S, Meroni L, Galli M. Rusconi S, et al. Chest. 1994 Jul;106(1):284-5. doi: 10.1378/chest.106.1.284. Chest. 1994. PMID: 8020287

4

Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection.

Antinori S, Galimberti L, Rusconi S, Zehender G, Esposito R, Galli M. Antinori S, et al. Among authors: rusconi s. Clin Exp Rheumatol. 1995 Nov-Dec;13 Suppl 13:S157-9. Clin Exp Rheumatol. 1995. PMID: 8730498

5

Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals.

Rusconi S, Santambrogio S, Di Marco A, Colombo MC, Citterio P, Adorni F, Galli M. Rusconi S, et al. AIDS Res Hum Retroviruses. 1998 Oct 10;14(15):1341-3. doi: 10.1089/aid.1998.14.1341. AIDS Res Hum Retroviruses. 1998. PMID: 9788675

6

Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects.

Rusconi S, Bulgheroni E, La Seta Catamancio S, Croce F, Lo Cicero M, Citterio P, Galli M. Rusconi S, et al. J Antimicrob Chemother. 2002 Feb;49(2):427-9. doi: 10.1093/jac/49.2.427. J Antimicrob Chemother. 2002. PMID: 11815597 Free article. No abstract available.

7

Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.

Chiesa E, Bini T, Adorni F, Capetti A, Rizzardini G, Faggion I, Mussini C, Sollima S, Melzi S, Bongiovanni M, Tordato F, Cicconi P, Castelnuovo B, Rusconi S, d'Arminio Monforte A. Chiesa E, et al. Among authors: rusconi s. Antivir Ther. 2003 Feb;8(1):27-35. Antivir Ther. 2003. PMID: 12713061

8

Analysis of the env V3 sequences obtained from patients with HIV type 1 infection treated with the immune modulant agent tucaresol.

Bulgheroni E, Bandera A, Galli M, Gori A, Rusconi S. Bulgheroni E, et al. Among authors: rusconi s. AIDS Res Hum Retroviruses. 2005 Sep;21(9):815-9. doi: 10.1089/aid.2005.21.815. AIDS Res Hum Retroviruses. 2005. PMID: 16218807 Clinical Trial.

9

Interleukin-2 therapy in patients with HIV infection.

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee; Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D. INSIGHT-ESPRIT Study Group, et al. N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175. N Engl J Med. 2009. PMID: 19828532 Free PMC article. Clinical Trial.

10

Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice.

Prosperi MC, Zazzi M, Punzi G, Monno L, Colao G, Corsi P, Di Giambenedetto S, Meini G, Ghisetti V, Bonora S, Pecorari M, Gismondo MR, Bagnarelli P, Carli T, De Luca A; ARCA Collaborative Group. Prosperi MC, et al. J Med Virol. 2010 Dec;82(12):1996-2003. doi: 10.1002/jmv.21927. J Med Virol. 2010. PMID: 20981785

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

422 results

Search Page